Variability of stimulant levels in nine sports supplements over a 9-month period

International Journal of Sport Nutrition and Exercise Metabolism

Volumn 26, Issue 5, 2016, Pages 413-420

  Attipoe, Selasi ^a   Cohen, Pieter A ^b   Eichner, Amy ^c   Deuster, Patricia A ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b CAMBRIDGE HEALTH ALLIANCE   (United States)

^c US Anti Doping Agency   (United States)

Author keywords

Dietary supplement; Sports supplement; Supplement label

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT; EPHEDRINE; METHYLEPHEDRINE; NORPSEUDOEPHEDRINE; OCTOPAMINE; OXEDRINE; PSEUDOEPHEDRINE; STRYCHNINE; N-METHYLEPHEDRINE; PHENYLPROPANOLAMINE;

ARTICLE; DIETARY SUPPLEMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; SPORT; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNITED STATES; ANALOGS AND DERIVATIVES; DOSE RESPONSE; FOOD PACKAGING; PILOT STUDY; TIME FACTOR;

CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPHEDRINE; FOOD LABELING; HUMANS; OCTOPAMINE; PHENYLPROPANOLAMINE; PILOT PROJECTS; PSEUDOEPHEDRINE; SPORTS; STRYCHNINE; SYNEPHRINE; TIME FACTORS; UNITED STATES;

EID: 84992217082     PISSN: 1526484X     EISSN: 15432742     Source Type: Journal    
DOI: 10.1123/ijsnem.2015-0177     Document Type: Article

References (44)

1. Abbate, V., Kicman, A.T., Evans-Brown, M., McVeigh, J., Cowan, D.A., Wilson, C.,. Walker, C.J. (2015). Anabolic steroids detected in bodybuilding dietary supplements-a significant risk to public health. Drug Testing and Analysis, 7(7), 609-618. PubMed Doi: 10.1002/dta.1728
2. Andrews, K.W., Schweitzer, A., Zhao, C., Holden, J.M., Roseland, J.M., Brandt, M.,. Douglass, L. (2007). The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. Analytical and Bioanalytical Chemistry, 389(1), 231-239. PubMed doi:10.1007/s00216-007-1437-2
3. Austin, K.G., Travis, J., Pace, G., & Lieberman, H.R. (2014). Analysis of 1, 3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. Drug Testing and Analysis, 6(7), 797-804. PubMed
4. Baume, N., Mahler, N., Kamber, M., Mangin, P., & Saugy, M. (2006). Research of stimulants and anabolic steroids in dietary supplements. Scandinavian Journal of Medicine & Science in Sports, 16(1), 41-48. PubMed doi:10.1111/j.1600-0838.2005.00442.x
5. Cancio, A., Eliason, M.J., Mercer, J., Tran, T., Deuster, P.A., & Stephens, M.B. (2012). Third-party certification of dietary supplements: prevalence and concerns. Military Medicine, 177(12), 1460-1463. PubMed doi:10.7205/MILMEDD-12-00069
6. Catlin, D.H., Leder, B.Z., Ahrens, B., Starcevic, B., Hatton, C.K., Green, G.A., & Finkelstein, J.S. (2000). Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. Journal of the American Medical Association, 284(20), 2618-2621. PubMed doi:10.1001/jama.284.20.2618
7. Cellini, M., Attipoe, S., Seales, P., Gray, R., Ward, A., Stephens, M., & Deuster, P.A. (2013). Dietary supplements: physician knowledge and adverse event reporting. Medicine and Science in Sports and Exercise, 45(1), 23-28. PubMed doi:10.1249/MSS.0b013e318269904f
8. Cohen, P.A. (2009). American roulette-contaminated dietary supplements. The New England Journal of Medicine, 361(16), 1523-1525. PubMed doi:10.1056/NEJMp0904768
9. Cohen, P.A., Attipoe, S., Travis, J., Stevens, M., & Deuster, P. (2013a). Caffeine content of dietary supplements consumed on military bases. JAMA Internal Medicine, 173(7), 592-594. PubMed doi:10.1001/jamainternmed. 2013.3254
10. Cohen, P.A., Benner, C., & McCormick, D. (2012). Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. Journal of General Internal Medicine, 27(1), 51-56. PubMed doi:10.1007/s11606-011-1828-0
11. Cohen, P.A., Travis, J.C., & Venhuis, B.J. (2014). A methamphetamine analog (N, alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6(7-8), 805-807. PubMed
12. Cohen, P.A., & Venhuis, B.J. (2013). Adulterated sexual enhancement supplements: more than mojo. JAMA Internal Medicine, 173(13), 1169-1170. PubMed doi:10.1001/jamainternmed.2013.854
13. Cohen, P.A., Zeijlon, R., Nardin, R., Keizers, P.H., & Venhuis, B. (2015). Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing beta-Methylphenylethylamine (BMPEA): A Case Report. Annals of Internal Medicine, Ahead of Print. PubMed doi:10.7326/L15-0106
14. Corby-Edwards, A.K. Regulation of Dietary Supplements. Congressional Research Service; May 6, 2013. Retrieved from http://www.law.umaryland.edu/marshall/crsreports/crsdocuments/R43062-11132012.pdf
15. de Hon, O., & Coumans, B. (2007). The continuing story of nutritional supplements and doping infractions. British Journal of Sports Medicine, 41(11), 800-805, discussion 805. PubMed doi:10.1136/bjsm.2007.037226
16. Dietary Supplement Health and Education Act of 1994, 103rd Congress, Pub. L. No. 103-417 (1994).
17. Geyer, H., Parr, M.K., Koehler, K., Mareck, U., Schanzer, W., & Thevis, M. (2008). Nutritional supplements crosscontaminated and faked with doping substances. Journal of Mass Spectrometry, 43(7), 892-902. PubMed doi:10.1002/jms.1452
18. Geyer, H., Parr, M.K., Mareck, U., Reinhart, U., Schrader, Y., & Schanzer, W. (2004). Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids-results of an international study. International Journal of Sports Medicine, 25(2), 124-129. PubMed doi:10.1055/s-2004-819955
19. Gonsalves, S., Stavinoha, T., Hite, L., Costa, J., Dilly, G., & Deuster, P.A. (2012). Dietary supplements in the Department of Defense: possible solutions to optimizing force readiness. Military Medicine, 177(12), 1464-1470. PubMed doi:10.7205/MILMED-D-12-00249
20. Green, G.A., Catlin, D.H., & Starcevic, B. (2001). Analysis of over-the-counter dietary supplements. Clinical Journal of Sport Medicine, 11(4), 254-259. PubMed doi:10.1097/00042752-200110000-00008
21. Harel, Z., Harel, S., Wald, R., Mamdani, M., & Bell, C.M. (2013). The Frequency and Characteristics of Dietary Supplement Recalls in the United States. JAMA Internal Medicine, 173(10), 926-928. PubMed
22. Jones, D.R., Kasper, K.B., & Deuster, P.A. (2015). Third-Party Evaluation: A Review of Dietary Supplements Dispensed by Military Treatment Facilities From 2007 to 2011. Military Medicine, 180(7), 737-741. PubMed doi:10.7205/MILMED-D-14-00500
23. Judkins, C., & Prock, P. (2012). Supplements and inadvertent doping-how big is the risk to athletes. Medicine and Sport Science, 59, 143-152. PubMed doi:10.1159/000341970
24. Judkins, C.M., Teale, P., & Hall, D.J. (2010). The role of banned substance residue analysis in the control of dietary supplement contamination. Drug Testing and Analysis, 2(9), 417-420. PubMed doi:10.1002/dta.149
25. Kamber, M., Baume, N., Saugy, M., & Rivier, L. (2001). Nutritional supplements as a source for positive doping cases? International Journal of Sport Nutrition and Exercise Metabolism, 11(2), 258-263. PubMed doi:10.1123/ijsnem.11.2.258
26. Khazan, M., Hedayati, M., Kobarfard, F., Askari, S., & Azizi, F. (2014). Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iranian Red Crescent Medical Journal, 16(3), e15344. PubMed
27. Kwiatkowska, D., Wojtowicz, M., Jarek, A., Goebel, C., Chajewska, K., Turek-Lepa, E.,. Kazlauskas, R. (2015). N, N-dimethyl-2-phenylpropan-1-amine-new designer agent found in athlete urine and nutritional supplement. Drug Testing and Analysis, 7(4), 331-335. PubMed doi:10.1002/dta.1741
28. Lanzarotta, A., Crowe, J.B., Witkowski, M., & Gamble, B.M. (2012). A multidisciplinary approach for the analysis of an adulterated dietary supplement where the active pharmaceutical ingredient was embedded in the capsule shell. Journal of Pharmaceutical and Biomedical Analysis, 67-68, 22-27. PubMed doi:10.1016/j.jpba.2012.04.023
29. Larimore, W.L., & O'Mathuna, D.P. (2003). Quality assessment programs for dietary supplements. The Annals of Pharmacotherapy, 37(6), 893-898. PubMed doi:10.1345/aph.1D031
30. Maughan, R.J., King, D.S., & Lea, T. (2004). Dietary supplements. Journal of Sports Sciences, 22(1), 95-113. PubMed doi:10.1080/0264041031000140581
31. Odoardi, S., Castrignano, E., Martello, S., Chiarotti, M., & Strano-Rossi, S. (2015). Determination of anabolic agents in dietary supplements by liquid chromatography-highresolution mass spectrometry. Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment, 32(5), 635-647. PubMed
32. Outram, S., & Stewart, B. (2015). Doping through supplement use: a review of the available empirical data. International Journal of Sport Nutrition and Exercise Metabolism, 25(1), 54-59. PubMed doi:10.1123/ijsnem.2013-0174
33. Petroczi, A., Taylor, G., & Naughton, D.P. (2011). Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements. Food and Chemical Toxicology, 49(2), 393-402. PubMed doi:10.1016/j. fct.2010.11.014
34. The Food and Drug Administration. (2005a). Dietary Supplement Labeling Guide: Chapter I. General Dietary Supplement Labeling. Retrieved from http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm070519.htm
35. The Food and Drug Administration. (2005b). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling. Retrieved from http://www.fda.gov/Food/Guidance-Regulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm070597.htm
36. The Food and Drug Administration. (2010). Guidance for Industry: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Small Entity Compliance Guide. Retrieved from http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ucm238182.htm#IX
37. The Food and Drug Administration. (2015). More supplement manufacturers complying with FDA GMP regulations, but room for improvement. Retrieved from http://www.naturalproductsinsider.com/blogs/supplement-law/2015/03/more-supplement-manufacturers-complying-with-fda.aspx
38. United States Government Accountability Office. Dietary Supplements: FDA May Have Opportunities to Expand Its Use of Reported Health Problems to Oversee Products. Washington, DC: United States Government Accountability Office; March 18, 2013
39. Vaclavik, L., Krynitsky, A.J., & Rader, J.I. (2014). Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies: a review. Analytical and Bioanalytical Chemistry, 406(27), 6767-6790. PubMed doi:10.1007/s00216-014-8159-z
40. van der Bijl, P., & Tutelyan, V.A. (2013). Dietary supplements containing prohibited substances. Voprosy Pitaniia, 82(6), 6-13. PubMed
41. van der Merwe, P.J., & Grobbelaar, E. (2005). Unintentional doping through the use of contaminated nutritional supplements. South African Medical Journal, 95(7), 510-511. PubMed
42. Van Thuyne, W., Van Eenoo, P., & Delbeke, F.T. (2006). Nutritional supplements: prevalence of use and contamination with doping agents. Nutrition Research Reviews, 19(1), 147-158. PubMed doi:10.1079/NRR2006122
43. Venhuis, B., Keizers, P., van Riel, A., & de Kaste, D. (2014). A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Testing and Analysis, 6(6), 578-581. PubMed doi:10.1002/dta.1664
44. Wu, C.H., Wang, C.C., & Kennedy, J. (2013). The prevalence of herb and dietary supplement use among children and adolescents in the United States: Results from the 2007 National Health Interview Survey. Complementary Therapies in Medicine, 21(4), 358-363. PubMed doi:10.1016/j. ctim.2013.05.001